Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients.
Dirven L, Musoro JZ, Coens C, Reijneveld JC, Taphoorn MJB, Boele FW, Groenvold M, van den Bent MJ, Stupp R, Velikova G, Cocks K, Sprangers MAG, King MT, Flechtner HH, Bottomley A.
Dirven L, et al. Among authors: velikova g.
Neuro Oncol. 2021 Aug 2;23(8):1327-1336. doi: 10.1093/neuonc/noab037.
Neuro Oncol. 2021.
PMID: 33598685
Free PMC article.